Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis

Future treatments of multiple sclerosis (MS), a chronic autoimmune neurodegenerative disease of the central nervous system (CNS), aim for simultaneous early targeting of peripheral immune function and neuroinflammation. Sphingosine-1-phosphate (S1P) receptor modulators are among the most promising d...

Descripción completa

Detalles Bibliográficos
Autores principales: Musella, Alessandra, Gentile, Antonietta, Guadalupi, Livia, Rizzo, Francesca Romana, De Vito, Francesca, Fresegna, Diego, Bruno, Antonio, Dolcetti, Ettore, Vanni, Valentina, Vitiello, Laura, Bullitta, Silvia, Sanna, Krizia, Caioli, Silvia, Balletta, Sara, Nencini, Monica, Buttari, Fabio, Stampanoni Bassi, Mario, Centonze, Diego, Mandolesi, Georgia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291065/
https://www.ncbi.nlm.nih.gov/pubmed/32455907
http://dx.doi.org/10.3390/cells9051290

Ejemplares similares

Ejemplares similares